<?xml version="1.0" encoding="UTF-8"?>
<p>It seems probable that there are geographic and ethnic differences in the clinical manifestations, epidemiology and mortality of PD. What is unclear is the exact nature of these differences and their cause. Black and Hispanic PD patients seem to be at increased risk of cognitive impairment but whether this is due to modifiable vascular risk factors, different rates of Alzheimer’s pathology, genetic factors or healthcare inequalities is unknown. In 
 <xref rid="jpd-10-jpd191763-t004" ref-type="table">Table 4</xref> we have set out what we believe should be research goals in this field. Further prospective clinico-pathological studies in multi-ethnic populations and in Black and Asian populations in countries other than Europe and the USA are important research goals.
</p>
